http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106543277-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4741 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6848 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate | 2016-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-106543277-B |
titleOfInvention | Endothelial cell antigen related to transplant rejection and application and kit thereof |
abstract | The invention discloses a human endothelial cell transplantation antigen related to transplant rejection and application thereof and a clinical detection kit. The endothelial cell antigen is keratin 1. Kits for detecting keratin 1 antibodies are useful for assessing the risk and status of clinical transplant rejection. The invention provides a new research target for researching the cause of the clinical organ transplantation rejection and predicting the occurrence of rejection reaction, and provides a new idea for establishing a new clinical organ transplantation risk evaluation system. |
priorityDate | 2016-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 444.